Use of Registries in Regulatory Decision Making
The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in Europe and invite you to:
- Stay updated on the latest in registry-based healthcare research and data utilization.
- Understand the European Medicines Agency’s guidelines for registry-based studies.
- Explore a compelling case study on registry-based real-world data in the regulatory process.
- Engage in a dynamic Q&A session with Health Technology Assessment experts and regulators
